Augmented Reality Platform for Telehealth Rehabilitation

用于远程医疗康复的增强现实平台

基本信息

  • 批准号:
    10698523
  • 负责人:
  • 金额:
    $ 60.67万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-06-01 至 2026-04-30
  • 项目状态:
    未结题

项目摘要

Restrictions imposed by the COVID-19 global pandemic have continued to alter the delivery of, and access to, healthcare across the nation. The resulting unmet health needs have had a disproportionate effect among older Americans as they continue to be at the highest mortality risk for the latest variants of COVID-19. Additional health disparities due to race, gender, residential location, and income have been exacerbated by COVID-19, further limiting equitable access to healthcare across the lifespan. These and other challenges have hastened the shift to other modes of healthcare such as telehealth. Yet, while Zoom and other apps have facilitated remote patient-clinician videoconferencing as the most common forms of telehealth, they do little to provide direct physical examination needed for evaluating musculoskeletal (MSK) deficits, planning therapeutic interventions, or guiding exercise compliance—essential components of evidence-based practice among rehabilitation practitioners. This is especially true for obtaining measures of joint mobility, alignment, posture, balance, strength, and function from osteoarthritis (OA) disorders; cornerstones for planning therapeutic interventions and guiding exercise compliance. Our team of biomechanists and computer vision engineers will continue our Phase I partnership with orthopedic and geriatric rehabilitation specialists at Massachusetts General Hospital (MGH) to advance the development of an augmented reality (AR) platform that enables clinicians to visualize key rehabilitative outcome measures to augment remote telehealth interactions during a video conference with their patient. Our Phase I work demonstrated the proof-of-concept that standard 3D-cameras available in common consumer devices (e.g., smartphones and tablets/PCs) when coupled with post-processing body tracking algorithms can deliver accurate rehabilitation outcome measures from patients with knee OA during a simulated telehealth visit. In Phase II we will expand our 3D body tracking algorithms and AR Platform architecture to support a broader set of assessment protocols that accommodate a diverse array of human and home environment factors (Aim 1); enable real-time cross-platform deployment for HIPAA-compliant communication and presentation of outcomes on a clinician’s screen (Aim 2); and validate the prototype during sessions involving clinic-based physical therapist and a person with knee OA remotely located in their home across urban, suburban, and rural locations (Aim 3). Stakeholders will complete self-report questionnaires for usability, acceptance, and perceived value followed by brief guided interviews and focus group evaluations. Our milestone is a clinically viable and operationally effective prototype AR Telehealth Platform that is favorably rated by clinicians and patients for use in the home. The long-term impact will expand access to rehabilitation specialists using telehealth tools that provide evidence-based evaluations of musculoskeletal deficits needed for guiding therapeutic interventions among at-risk segments of the population.
COVID-19的全球大流行施加的限制继续改变并访问的限制 全国医疗保健。由此产生的未满足的健康需求在较旧的情况下产生了不成比例的影响 美国人继续对Covid-19的最新变体处于最高死亡率风险。额外的 由于种族,性别,居民地点和收入而导致的健康差异已被Covid-19加剧, 进一步限制了整个生命周期中公平获得医疗保健的机会。这些和其他挑战已经使 转向其他医疗保健模式,例如远程医疗。但是,虽然Zoom和其他应用程序已准备好远程 患者临床医生的视频会议是最常见的远程医疗形式,他们无济于事 评估肌肉骨骼(MSK)所需的体格检查定义,计划治疗干预措施, 或指导锻炼合规性 - 康复中循证实践的必不可少的组成部分 从业者。对于获得关节迁移率,一致性,姿势,平衡, 骨关节炎(OA)疾病的力量和功能;计划治疗干预措施的基石 并指导锻炼合规性。我们的生物力学和计算机视觉工程师团队将继续我们的 与马萨诸塞州总医院的骨科和老年康复专家的第一阶段合作伙伴关系 (MGH)推进增强现实平台的开发,该平台使临床医生能够可视化 在与与远程远程医疗互动相互作用的关键康复结果指标上 他们的病人。我们的阶段我的工作证明了概念的证明,标准的3D-Cameras可用 与后处理的身体相结合时,常见的消费者设备(例如智能手机和平板电脑/PC) 跟踪算法可以在膝盖OA患者中提供准确的康复结果指标 模拟远程医疗访问。在第二阶段,我们将扩展我们的3D身体跟踪算法和AR平台 建筑以支持更广泛的评估协议,以适应潜水员的人类和 家庭环境因素(目标1);启用符合HIPAA的实时跨平台部署 在临床屏幕上的结局进行沟通和呈现(AIM 2);并验证原型 涉及基于诊所的物理治疗师和膝盖OA远程的人会议 遍布城市,郊区和农村地区(AIM 3)。利益相关者将完成自我报告问卷 可用性,接受和感知的价值,然后进行简短的指导访谈和焦点小组评估。 我们的里程碑是一个在临床上可行且在操作上有效的原型AR远程医疗平台 临床医生和患者在家庭中使用的评分很高。长期影响将扩大对 使用远程医疗工具的康复专家,可提供基于证据的肌肉骨骼评估 指导人口危险中的治疗干预所需的缺陷。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Bhawna Shiwani其他文献

Bhawna Shiwani的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Bhawna Shiwani', 18)}}的其他基金

Whole-Body VR for Pediatric Yoga Therapy
用于小儿瑜伽治疗的全身 VR
  • 批准号:
    10481791
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:
NeuroVision™: A Smartphone Application for Neurology and Telemedicine
NeuroVision™:用​​于神经病学和远程医疗的智能手机应用程序
  • 批准号:
    10663164
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:
NeuroVision™: A Smartphone Application for Neurology and Telemedicine
NeuroVision™:用​​于神经病学和远程医疗的智能手机应用程序
  • 批准号:
    10384252
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:

相似国自然基金

CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
  • 批准号:
  • 批准年份:
    2021
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
CTCF通过介导染色质高级结构调控非小细胞肺癌发生发展的机制研究
  • 批准号:
    32100463
  • 批准年份:
    2021
  • 资助金额:
    24.00 万元
  • 项目类别:
    青年科学基金项目
发展高级固体核磁方法探索功能材料的表界面化学
  • 批准号:
    21922410
  • 批准年份:
    2019
  • 资助金额:
    120 万元
  • 项目类别:
    优秀青年科学基金项目
TACSTD2在卵巢高级别浆液性癌发生发展中的作用及分子机制研究
  • 批准号:
    81402157
  • 批准年份:
    2014
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

MagPAD: Magnetic Puncture, Access, and Delivery of Large Bore Devices to the Heart Via the Venous System
MagPAD:通过静脉系统对大口径装置进行磁穿刺、进入和输送至心脏
  • 批准号:
    10600737
  • 财政年份:
    2023
  • 资助金额:
    $ 60.67万
  • 项目类别:
Evaluation of novel tomosynthesis density measures in breast cancer risk prediction
新型断层合成密度测量在乳腺癌风险预测中的评价
  • 批准号:
    10680241
  • 财政年份:
    2023
  • 资助金额:
    $ 60.67万
  • 项目类别:
Novel patient-derived 3D platform for detecting TDP-43 proteinopathy and associated biomarkers for ALS/FTD
用于检测 TDP-43 蛋白病和 ALS/FTD 相关生物标志物的新型患者衍生 3D 平台
  • 批准号:
    10395206
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:
Machine Learning-based Imaging Biomarkers for Metabolic and Age-related Diseases
基于机器学习的代谢和年龄相关疾病的成像生物标志物
  • 批准号:
    10707354
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:
Mechanotransduction mechanisms of ovarian aging
卵巢衰老的机械传导机制
  • 批准号:
    10429460
  • 财政年份:
    2022
  • 资助金额:
    $ 60.67万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了